StockDrifts LogoStockDrifts

Dauntless Investment Group 13F Portfolio

Portfolio Manager
Dauntless Investment Group LLC
Performance
+83.54% (2026 Q2)
AUM (13F)
$127.28M
# of Holdings
64
Performance Rank
N/A
Allocation (Top 20)
72.29%
Latest filing
Q2 2026

Dauntless Investment Group LLC Holdings Map

Top 50 Dauntless Investment Group LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
AEON
AEON BIOPHARMA INC
15.58%12.49M$9.0M
+394.12%(+9.96M)
2025-Q2: 1.13M shares2025-Q3: 1.13M shares2025-Q4: 2.13M shares2026-Q1: 2.53M shares2026-Q2: 12.49M shares
$2.42(-88.49%)
2026-06-30
KZIA
KAZIA THERAPEUTICS LTD
8.65%354.2K$5.0M
+343.69%(+274.38K)
2025-Q2: 115.8K shares2025-Q3: 118.1K shares2025-Q4: 1 shares2026-Q1: 79.8K shares2026-Q2: 354.2K shares
$9.90(+31.52%)
2026-06-30
VLO
VALERO ENERGY CORP
4.8%10.6K$2.8Mnew2025-Q2: 0 shares2025-Q3: 5.4K shares2025-Q4: 4.2K shares2026-Q1: 0 shares2026-Q2: 10.6K shares
$214.89(+59.58%)
2026-06-30
JOE
ST JOE CO
3.93%36.2K$2.3M
+12.14%(+3.91K)
2025-Q2: 26.0K shares2025-Q3: 29.2K shares2025-Q4: 42.7K shares2026-Q1: 32.3K shares2026-Q2: 36.2K shares
$51.86(+32.44%)
2026-06-30
ADAG
ADAGENE INC
3.91%537.2K$2.3M
+1444.87%(+502.45K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 34.8K shares2026-Q2: 537.2K shares
$3.92(-3.17%)
2026-06-30
ESTA
ESTABLISHMENT LABS HLDGS INC
3.83%25.7K$2.2M
+172.89%(+16.30K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 12.5K shares2026-Q1: 9.4K shares2026-Q2: 25.7K shares
$65.37(+18.21%)
2026-06-30
IRS
IRSA INVERSIONES Y REP S A
3.39%126.5K$2.0Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 126.5K shares
$15.47(-5.17%)
2026-06-30
AZTR
AZITRA INC
3.28%11.29M$1.9M
+1129118.60%(+11.29M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 1.0K shares2026-Q2: 11.29M shares
$0.21(-31.03%)
2026-06-30
LINC
LINCOLN EDL SVCS CORP
2.69%31.0K$1.5M
-47.77%(-28.39K)
2025-Q2: 30.5K shares2025-Q3: 56.0K shares2025-Q4: 56.0K shares2026-Q1: 59.4K shares2026-Q2: 31.0K shares
$18.98(+59.01%)
2026-06-30
TLSA
TIZIANA LIFE SCIENCES LTD
2.58%1.16M$1.5M
-46.33%(-1.00M)
2025-Q2: 3.42M shares2025-Q3: 2.74M shares2025-Q4: 1.76M shares2026-Q1: 2.17M shares2026-Q2: 1.16M shares
$1.16(-12.63%)
2026-06-30

About Dauntless Investment Group LLCโ€™s portfolio

Dauntless Investment Group LLC reports $127.28M in US-listed equity holdings across 64 positions in its most recent 13F filing. Its largest disclosed positions are AEON (15.6%), KZIA (8.7%) and VLO (4.8%). The top 20 holdings account for 72.29% of reported assets. Its disclosed equity book has returned +180.86% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
AEON โ€” 18.1% ($8.98M)KZIA โ€” 10.0% ($4.99M)VLO โ€” 5.6% ($2.77M)JOE โ€” 4.6% ($2.27M)ADAG โ€” 4.5% ($2.26M)ESTA โ€” 4.4% ($2.21M)IRS โ€” 3.9% ($1.95M)AZTR โ€” 3.8% ($1.89M)LINC โ€” 3.1% ($1.55M)TLSA โ€” 3.0% ($1.49M)Other โ€” 39.0% ($19.40M)
61%in top 10
  • AEON18.1%
  • KZIA10.0%
  • VLO5.6%
  • JOE4.6%
  • ADAG4.5%
  • ESTA4.4%
  • IRS3.9%
  • AZTR3.8%
  • LINC3.1%
  • TLSA3.0%
  • Other39.0%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
17
VLOVALERO ENERGY CORP4.8%
IRSIRSA INVERSIONES Y REP S A3.4%
LOMALOMA NEGRA CORP2.3%
NOWSERVICENOW INC1.8%
+13 opened
Added to
16
AEONAEON BIOPHARMA INC+394.1%
KZIAKAZIA THERAPEUTICS LTD+343.7%
ADAGADAGENE INC+1444.9%
AZTRAZITRA INC+1129118.6%
+12 more
Trimmed
15
INVAINNOVIVA INC-98.7%
TOITHE ONCOLOGY INSTITUTE INC-64.6%
LINCLINCOLN EDL SVCS CORP-47.8%
TLSATIZIANA LIFE SCIENCES LTD-46.3%
+11 more

Unlock alerts, watchlists & AI chat

Sign up free to track Dauntless Investment Group LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Dauntless Investment Group LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2044285). View Dauntless Investment Group LLCโ€™s 13F filings on SEC

More 13F analyses

View all